Vaccine up to Date: RNA Vaccines and RNA Immunotherapeutics
The body of human being is considered as a sort of biological system. Such system ends up to building blocks, the cells. These building blocks stand as a miniaturized biological system that contained an array of several kinds of bio-macromolecules like proteins, carbohydrates, lipids, and nucleic acids. These cellular biomacromolecules, in turn act as molecular machines inside the cells.
Editorial
discovered and to be discovered immune potentials (Table 1). The today notion holds that long non-coding RNA functioned as regulators of infection processs, immune response to infections, tumorogenic and tumorocidal processes, and vaccine immune-adjuvants [5]. As well as the coding RNA act as vaccines. Therefore, what promising now is that coding and long non-coding RNA vaccine and vaccine adjuvants which are still in their infancy state [6], suggest an optimistic prospectus pinpointing that these RNA vaccine preparations are promising for prophylaction and /or treatment (Tables 2- 4) of some infectious and cancerous diseases [7, 8, 9, 10]. May and may not be we are still in life witnessing of the integration of the biology of RNA, biology of DNA (Since DNA vaccine were already known) with current vaccinology and to a step further towards Nucleic acid vaccines as main branch in continuum with the current molecular vaccines.
- Tables mRNA
- Preventive and therapeutic RNA vaccines
- Coding miRNA
- Immune regulation on innate and adaptive immunity.
- Noncoding miRNA
- Regulation of development and function of Immune cells and
- Regulation of innate and adaptive immune response.
Table 1: The immune functions of RNA [8-10].
| Viral Infection | Influenzae, Rabies, HIV. | ||
|---|---|---|---|
| Bacterial | Tuberculosis. |
Table 2: Immune mechanisms behind RNA vaccine in vaccinated (6).
- Preventative and therapeutic cancer vaccines
- Melanoma
- Lung cancer
- Prostate cancer
- Check point inhibitor, siRNA
Table 3: RNA based preventive and therapeutic cancer vaccines preclinical and limited clinical phase [6].
- Preparation of RNA vaccine, stabilization, naked or encapsulated.
- Manipulated into APC, transcribed, and translated into protein of vaccine specificity.
- Triggering the TH0 and activated into TH1, TH2 which in turn activate naive B cell.
- Clonal expansion of effector antibody producing, and memory B cells
- Immune conversion of baseline vaccine specific antibody to clinical vaccine specific antibody titres that may mediate immune protection
Table 4: Immune mechanisms behind RNA vaccine in vaccinated (6).
References 1. Clegg CJ (2000) Introduction to advanced biology, Murray, London, pp. 9-24.
2. Wilson R, Walker J (2010) Principles and Techniques
of Biochemistry and Molecular Biology. In: Keith Wilson & John Walker (Eds.), (7th edn), Cambridge University Press, Cambridge, pp. 138-262.
3. Wahid F, Shehzad A, Khan T, Kim YY, (2010)
MicroRNAs, synthesis, mechanisms, function and recent clinical trails, Bichemica Biophysica Acta, Molecular Cell researchs 1803(11): 1231-1243.
4. Lewin B (2000) Genes VII. In: Benjamin Lewin, Oxford
University Press, Oxford, pp. 232-272.
5. Li Z, Rana TM (2014) Decoding and non-coding RNA;
Prospective of Lnc RNA mediated innate immune regulation, RNA Biol 11(8): 979-985.
6. Hubaud A (2015) A Plog on RNA Vaccine: A Novel
technology to prevent and treat diseases, Brigham and Womens Hospital, Harvard Medical School.
7. Sayour EJ, Sanchez-Perez L, Flores C, Mitchell DA
(2015) Bridging infectious disease vaccines with cancer immunotherapy: role of RNA based immunotheraputics. J Immunother Cancer 3: 13.
8. Ansel KM (2013) RNA regulation in the immune system. Immunol Rev 253(1): 5-11.
9. Geng H, Tan XD (2016) Functional diversity of long non-coding RNA in Immune regulation. Gene & Disease 3(1): 72-81.
10. McNamara MA, Nair SK, Holl EK (2015) RNA based vaccines in cancer immunotherapy. J Immunol Res 794528.
- Update on Malariology and Malaria Vaccines
- Addressing Vaccine Hesitancy in the Age of Measles Resurgence: A Mini-Review
- Exploring Barriers and Facilitators of Group Antenatal Care Implementation in Kaduna State, Nigeria: A Qualitative Evaluation
- The Role of IL-11 in Regenerative Medicine and Tissue Engineering
- New Prediction of Mortality rate of Covid -19 According to WHO Estimation
- Measles Vaccine in Kano, Northern Nigeria: Past, Present and Future